Filing Details

Accession Number:
0001261380-13-000041
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-14 16:48:44
Reporting Period:
2013-06-12
Filing Date:
2013-06-14
Accepted Time:
2013-06-14 16:48:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1006045 Iridex Corp IRIX Electromedical & Electrotherapeutic Apparatus (3845) 770210467
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1422484 H James Mackaness 1212 Terra Bella Avenue
Mountain View CA 94043
Cfo And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-12 300 $2.49 44,930 No 4 M Direct
Common Stock Disposition 2013-06-12 300 $5.55 44,630 No 4 S Direct
Common Stock Acquisiton 2013-06-12 100 $0.90 21,900 No 4 M Direct
Common Stock Disposition 2013-06-12 100 $5.55 21,800 No 4 S Direct
Common Stock Acquisiton 2013-06-13 1,000 $2.49 44,630 No 4 M Direct
Common Stock Disposition 2013-06-13 1,000 $5.20 43,630 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Right to Buy Disposition 2013-06-12 300 $0.00 300 $2.49
Common Stock Stock Option Right to Buy Disposition 2013-06-12 100 $0.00 100 $0.90
Common Stock Stock Option Right to Buy Disposition 2013-06-13 1,000 $0.00 1,000 $2.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
44,630 2008-02-02 2015-01-02 No 4 M Direct
21,800 2009-01-11 2015-12-11 No 4 M Direct
43,630 2008-02-02 2015-01-02 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was pursuant to the Reporting Person's Rule 10b5-1 Selling Plan that was effective March 5, 2013.
  2. This option was granted pursuant to IRIDEX Corporation's incentive 1998 Stock Plan and is exempt pursuant to Rule 16b-3.
  3. The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.